The Motley Fool

Key Data Points

Primary metrics and data points about Amicus Therapeutics, Inc..
Current Price: $14.87
Prev Close: $14.85
Open: $14.71
Bid: $14.67
Ask: $16.87
Day's Range: $14.56 - $15.17
52wk Range: $5.13 - $18.83
Volume: 914,566
Avg Vol 1,833,026
Market Cap: $2B
P/E (ttm): -14.85
EPS (ttm): ($1.00)
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Amicus Therapeutics, Inc..

A clinical-stage biopharmaceutical company, which focused on the discovery, development and commercialization of novel small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

FOLD vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Amicus Therapeutics, Inc..
CAPS Rating 2 out of 5
 
106 Outperform
29 Underperform
CAPS All Stars
 
27 Outperform
11 Underperform

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John F. Crowley, CEO

100% Approve

Based on 7 Ratings

Powered by

More Details about Amicus Therapeutics, Inc.

Primary metrics and data points about Amicus Therapeutics, Inc..